(Total Views: 502)
Posted On: 11/26/2019 4:20:42 PM
Post# of 151

$MRK News Article - Merck's KEYTRUDA (pembrolizumab) Now Approved in China for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) in Combination with Chemotherapy https://marketwirenews.com/news-releases/merc...84097.html


My Twitter: WhyteStocks